Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy

Annals of Neurology

Volumn 59, Issue 2, 2006, Pages 289-297

  Reed, Patrick ^a   Porter, Neil C ^a   Strong, John ^a   Pumplin, David W ^a   Corse, Andrea M ^b   Luther, Paul W ^a   Flanigan, Kevin M ^c   Bloch, Robert J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BICEPS BRACHII MUSCLE; CONFOCAL MICROSCOPY; DELTOID MUSCLE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; MUSCLE FIBRIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SARCOLEMMA; SKELETAL MUSCLE; TANDEM REPEAT; TISSUE SECTION;

CYTOSKELETON; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; SARCOLEMMA; SPECTRIN;

EID: 32044454237     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20750     Document Type: Article

References (55)

1. Fitzsimons RB. Facioscapulohumeral muscular dystrophy. Curr Opin Neurol 1999;12:501-511.
2. Gurwin EB, Fitzsimons RB, Sehmi KS, et al. Retinal telangiectasis in facioscapulohumeral muscular dystrophy with deafness. Arch Ophthalmol 1985;103:1695-1700.
3. Fitzsimons RB, Gurwin EB, Bird AC. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain 1987;110:631-648.
4. Akiyama C, Suzuki H, Nonaka I. [A case of facioscapulohumeral muscular dystrophy with infantile spasms, sensorineural deafness and retinal vessel abnormality]. No To Hattatsu 1991;23:395-399.
5. Pauleikhoff D, Bornfeld N, Bird AC, et al. Severe visual loss associated with retinal telangiectasis and facioscapulohumeral muscular dystrophy. Graefes Arch Clin Exp Ophthalmol 1992;230:362-365.
6. Tekin NF, Saatci AO, Kavukcu S. Vascular tortuosity and Coats'-like retinal changes in facioscapulohumeral muscular dystrophy. Ophthalmic Surg Lasers 2000;31:82-83.
7. Padberg GW. MD Thesis, Facioscapulohumeral disease. Leiden University, Leiden, The Netherlands, 1982.
8. Lunt PW. 44th ENMC International Workshop: Facioscapulohumeral Muscular Dystrophy: Molecular Studies 19-21 July 1996, Naarden, The Netherlands. Neuromuscul Disord 1998;8:126-130.
9. Wijmenga C, Padberg GW, Moerer P, et al. Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. Genomics 1991;9:570-575.
10. Wijmenga C, Hewitt JE, Sandkuijl LA, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992;2:26-30.
11. Wijmenga C, Sandkuijl LA, Moerer P, et al. Genetic linkage map of facioscapulohumeral muscular dystrophy and five polymorphic loci on chromosome 4q35-qter. Am J Hum Genet 1992;51:411-415.
12. Mills KA, Buetow KH, Xu Y, et al. Genetic and physical mapping on chromosome 4 narrows the localization of the gene for facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet 1992;51:432-439.
13. Mathews KD, Mills KA, Bosch EP, et al. Linkage localization of facioscapulohumeral muscular dystrophy (FSHD) in 4q35. Am J Hum Genet 1992;51:428-431.
14. Gilbert JR, Stajich JM, Speer MC, et al. Linkage studies in facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet 1992;51:424-427.
15. Weiffenbach B, Bagley R, Falls K, et al. Linkage analyses of five chromosome 4 markers localizes the facioscapulohumeral muscular dystrophy (FSHD) gene to distal 4q35. Am J Hum Genet 1992;51:416-423.
16. Upadhyaya M, Lunt P, Sarfarazi M, et al. The mapping of chromosome 4q markers in relation to facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet 1992;51:404-410.
17. Sarfarazi M, Wijmenga C, Upadhyaya M, et al. Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am J Hum Genet 1992;51:396-403.
18. Wijmenga C, Frants RR, Brouwer OF, et al. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 1990;336:651-653.
19. Winokur ST, Bengtsson U, Feddersen J, et al. The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res 1994;2:225-234.
20. Lunt PW, Jardine PE, Koch MC, et al. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 1995;4:951-958
21. (erratum, Hum Mol Genet 1995;4:1243-1244).
22. Miura K, Kumagai T, Matsumoto A, et al. Two cases of chromosome 4q35-linked early onset facioscapulohumeral muscular dystrophy with mental retardation and epilepsy. Neuropediatrics 1998;29:239-241
23. Funakoshi M, Goto K, Arahata K. Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy. Neurology 1998;50:1791-1794.
24. van der Maarel SM, Frants RR. The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy. Am J Hum Genet 2005;76:375-386.
25. Gabellini D, Green MR, Tupler R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002;110:339-348.
26. Masny PS, Bengtsson U, Chung SA, et al. Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? Hum Mol Genet 2004;13:1857-1871.
27. Tam R, Smith KP, Lawrence JB. The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres. J Cell Biol 2004;167:269-279.
28. Lemmers RJ, de Kievit P, Sandkuijl L, et al. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet 2002;32:235-236.
29. Lemmers RJ, Wohlgemuth M, Frants RR, et al. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. Am J Hum Genet 2004;75:1124-1130.
30. Gabriels J, Beckers MC, Ding H, et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 1999;236:25-32.
31. Hewitt JE, Lyle R, Clark LN, et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 1994;3:1287-1295.
32. Frigeri A, Nicchia GP, Repetto S, et al. Altered aquaporin-4 expression in human muscular dystrophies: a common feature? FASEB J 2002;16:1120-1122.
33. Schotland DL, Bonilla E, Wakayama Y. Freeze fracture studies of muscle plasma membrane in human muscular dystrophy. Acta Neuropathol (Berl) 1981;54:189-197.
34. Spuler S, Engel AG. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies. Neurology 1998;50:41-46.
35. Spence HJ, Chen YJ, Winder SJ. Muscular dystrophies, the cytoskeleton and cell adhesion. Bioessays 2002;24:542-552.
36. Michele DE, Campbell KP. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem 2003;278:15457-15460.
37. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-928.
38. Petrof BJ, Shrager JB, Stedman HH, et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993;90:3710-3714.
39. Williams MW, Bloch RJ. Extensive but coordinated reorganization of the membrane skeleton in myofibers of dystrophic (mdx) mice. J Cell Biol 1999;144:1259-1270.
40. Kontrogianni-Konstantopoulos A, Jones EM, Van Rossum DB, et al. Obscurin is a ligand for small ankyrin 1 in skeletal muscle. Mol Biol Cell 2003;14:1138-1148.
41. Ursitti JA, Martin L, Resneck WG, et al. Spectrins in developing rat hippocampal cells. Brain Res Dev Brain Res 2001;129:81-93.
42. Williams MW, Bloch RJ. Differential distribution of dystrophin and β-spectrin at the sarcolemma of fast twitch skeletal muscle fibers. J Muse Res Cell Motil 1999;20:383-393.
43. Kontrogianni-Konstantopoulos A, Catino DH, Strong JC, et al. Obscurin regulates the organization of myosin into A bands. Am J Physiol Cell Physiol 2004;287:C209-C217.
44. Williams MW, Resneck WG, Bloch RJ. Membrane skeleton of innervated and denervated fast- and slow-twitch muscle. Muscle Nerve 2000;23:590-599.
45. Street SF. Lateral transmission of tension in frog myofibers: a myofibrillar network and transverse cytoskeletal connections are possible transmitters. J Cell Physiol 1983;114:346-364.
46. Pardo JV, Siliciano JD, Craig SW. A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci USA 1983;80:1008-1012.
47. Bloch RJ, Capetanaki Y, O'Neill A, et al. Costameres: repeating structures at the sarcolemma of skeletal muscle. Clinical orthopaedics and related research. 2002:5203-5210.
48. Ryder-Cook AS, Sicinski P, Thomas K, et al. Localization of the mdx mutation within the mouse dystrophin gene. EMBO J 1988;7:3017-3021.
49. Porter GA, Dmytrenko GM, Winkelmann JC, et al. Dystrophin colocalizes with β-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle. J Cell Biol 1992;117:997-1005.
50. Reed PW, Mathews KD, Mills KA, et al. The sarcolemma in the Large(myd) mouse. Muscle Nerve 2004;30:585-595.
51. Bloch RJ, Gonzalez-Serratos H. Lateral force transmission across costameres in skeletal muscle. Exer Sport Sci Rev 2003;31:73-78.
52. Bouju S, Pietu G, Le Cunff M, et al. Exclusion of muscle specific actinin-associated LIM protein (ALP) gene from 4q35 facioscapulohumeral muscular dystrophy (FSHD) candidate genes. Neuromusc Disord 1999;9:3-10.
53. Rijkers T, Deidda G, van Koningsbruggen S, et al. FRG2, an FSHD candidate gene, is transcriptionally up regulated in differentiating primary myoblast cultures of FSHD patients. J Med Genet 2004;41:826-836.
54. Laoudj-Chenivesse D, Carnac G, Bisbal C, et al. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J Mol Med 2005;83:216-224.
55. van Deutekom JC, Lemmers RJ, Grewal PK, et al. Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35. Hum Mol Genet 1996;5:581-590.